|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.94 USD | -2.42% |
|
-8.86% | -17.37% |
| 01:40pm | Citigroup Downgrades ResMed to Neutral From Buy, Adjusts Price Target to $235 From $270 | MT |
| 10:48am | Citi Downgrades ResMed to Neutral From Buy; Price Target is AU$34 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.42% | -8.86% | +3.27% | -13.56% | -17.37% | -21.67% | -8.99% | -19.99% | +208.92% | 29.41B | |
| +0.91% | +2.52% | +12.02% | +3.20% | -8.42% | +24.76% | +0.76% | +3.18% | +242.81% | 196B | |
| +0.79% | -5.46% | -1.77% | -10.85% | -27.75% | -20.77% | +17.93% | +28.37% | +447.32% | 144B | |
| +0.33% | +2.91% | +10.02% | +1.73% | -12.96% | +0.76% | -16.57% | -28.00% | +145.87% | 141B | |
| -0.07% | +0.31% | -4.32% | -29.19% | -53.08% | -57.12% | -15.25% | +3.90% | +89.34% | 66.54B | |
| +0.04% | -3.36% | +6.61% | +17.74% | +7.89% | +17.50% | -1.19% | -13.83% | +159.12% | 53.09B | |
| +2.75% | +1.98% | +1.74% | -5.87% | -20.81% | -22.66% | -30.53% | -34.13% | - | 44.12B | |
| -0.54% | +2.07% | +2.08% | +13.45% | -2.04% | +11.01% | +11.69% | -10.70% | +187.22% | 37.93B | |
| -0.23% | -0.96% | +4.89% | +15.58% | -1.20% | +23.37% | +39.37% | +1.85% | +153.69% | 36.96B | |
| +1.62% | +1.35% | +1.47% | -10.99% | -19.88% | -11.73% | -19.27% | - | - | 29.43B | |
| +0.04% | -2.46% | +13.58% | +49.30% | +44.52% | +92.38% | +0.38% | -60.80% | +29.95% | 28.78B | |
| +0.12% | -1.67% | +4.38% | -0.12% | +3.66% | +16.77% | +23.21% | -33.65% | +15.43% | 26.19B | |
| -1.34% | -0.24% | -7.52% | -11.70% | -26.66% | -36.82% | -53.04% | -69.54% | - | 25.25B | |
| -0.02% | -0.97% | +11.24% | +20.74% | +15.61% | +13.59% | -8.53% | -26.97% | +100.92% | 12.53B | |
| +1.25% | +0.42% | +4.26% | +13.20% | -10.53% | +4.04% | -19.44% | -20.24% | +90.66% | 11.53B | |
| -0.20% | -2.46% | +5.65% | +53.21% | +27.00% | +38.46% | -19.53% | -24.67% | +139.13% | 9.14B | |
| -12.45% | +29.35% | +23.23% | +33.67% | - | - | - | - | - | 5.19B | |
| -2.53% | -2.28% | +9.66% | -21.22% | -18.39% | +39.10% | - | - | - | 4.35B | |
| -6.90% | -10.83% | +1.35% | +3.04% | -13.43% | -16.89% | -42.01% | - | - | 3.44B | |
| -6.24% | -12.20% | -2.94% | -16.70% | -2.30% | +45.29% | +15.80% | - | - | 3.33B | |
| Average | -1.26% | +1.20% | +4.94% | +5.23% | -7.17% | +7.34% | -6.96% | -20.35% | +154.64% | 45.4B | |
| Weighted average by Cap. | +0.29% | -0.60% | +5.25% | +0.51% | -13.10% | +1.54% | -2.54% | -8.49% | +215.30% |
- Stock Market
- Stocks
- RMD Stock
- Sector ResMed, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition